obuprazine
AssetAlso TRTL-107
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Schizophrenia
Phase 2, businesswire.com, 12 Oct 2026
In the full profile
- Owner and partners2
- Competitors6
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.